Vol 50 No 05

RP appears more effective against high-risk prostate cancer

April 28, 2022

"It’s very possible that the PSA screening-detected high-risk prostate cancer portends a more favorable outlook when compared with the pre-PSA era, regardless of the type of primary therapy utilized," writes Badar M. Mian, MD.

Dr. Nickel discusses saw palmetto as a complementary treatment for LUTS

March 11, 2022

"We shouldn't outright provide a negative attitude to our patients who are looking for alternatives that [serve as] complementary medicine, [like] herbal or phytotherapeutic agents," says J. Curtis Nickel, MD, FRCSC.